BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 6279346)

  • 1. The effect of treatment on growth and deformity in hypophosphatemic vitamin D-resistant rickets.
    Loeffler RD; Sherman FC
    Clin Orthop Relat Res; 1982; (162):4-10. PubMed ID: 6279346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypophosphatemic rickets: still misdiagnosed and inadequately treated.
    Greene WB; Kahler SG
    South Med J; 1985 Oct; 78(10):1179-84. PubMed ID: 2996152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic hypophosphatemic osteopathy ("rachitis"). Clinico-osteological review].
    Swoboda W
    Acta Med Austriaca; 1977; 4(4-9):156-60. PubMed ID: 205074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early diagnosis and early treatment of hypophosphatemic vitamin D-resistant rickets].
    Schaumberger E; Hohenauer L; Sommer R
    Klin Padiatr; 1986; 198(1):44-8. PubMed ID: 3007858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological and bone histomorphometric studies in hypophosphatemic vitamin-resistant rickets treated with 1,25-(OH)2D and phosphorus].
    Dumas R; Guermoud C; Garabedian M; Meunier JP
    Arch Fr Pediatr; 1985; 42(7):507-10. PubMed ID: 3002291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of phosphate supplementation on linear growth in children with X-linked hypophosphatemia.
    Seikaly MG; Browne RH; Baum M
    Pediatrics; 1994 Oct; 94(4 Pt 1):478-81. PubMed ID: 7936855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-azotemic refractory rickets in Indian children.
    Bajpai A; Bardia A; Mantan M; Hari P; Bagga A
    Indian Pediatr; 2005 Jan; 42(1):23-30. PubMed ID: 15695854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early history of familial hypophosphataemic vitamin D-resistant rickets. Report of three cases observed since birth.
    Schimert G; Fanconi A
    Helv Paediatr Acta; 1983 Oct; 38(4):383-98. PubMed ID: 6317614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tubular and intestinal phosphate transport in vitamin D-resistant (hypophosphatemic) rickets (author's transl)].
    Schabel F; Kurz R; Madreiter H; Reinken L; Zieglauer H
    Padiatr Padol; 1977; 12(2):152-7. PubMed ID: 193082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dentin structure in familial hypophosphatemic rickets: benefits of vitamin D and phosphate treatment.
    Chaussain-Miller C; Sinding C; Septier D; Wolikow M; Goldberg M; Garabedian M
    Oral Dis; 2007 Sep; 13(5):482-9. PubMed ID: 17714351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophosphataemic vitamin D-resistant rickets; an observation on height and serum inorganic phosphate in untreated cases.
    Steendijk R; Latham SC
    Helv Paediatr Acta; 1971 Jun; 26(2):179-84. PubMed ID: 4333257
    [No Abstract]   [Full Text] [Related]  

  • 14. Familial hypophosphatemic vitamin D-resistant rickets.
    Hirschman GH; Rao DD
    Pediatr Clin North Am; 1976 Nov; 23(4):895-6. PubMed ID: 186749
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of growth hormone treatment on final height, phosphate metabolism, and bone mineral density in children with X-linked hypophosphatemic rickets.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Saggese G
    J Pediatr; 2001 Feb; 138(2):236-43. PubMed ID: 11174622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical and surgical therapy of familial hypophosphatemic vitamin D resistant rickets with ambulation disorders].
    Berio A; Pinelli G
    Minerva Pediatr; 1997 Oct; 49(10):487-93. PubMed ID: 9557495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linear growth in relation to the circulating concentrations of insulin-like growth factor I, parathyroid hormone, and 25-hydroxy vitamin D in children with nutritional rickets before and after treatment: endocrine adaptation to vitamin D deficiency.
    Soliman AT; Al Khalaf F; Alhemaidi N; Al Ali M; Al Zyoud M; Yakoot K
    Metabolism; 2008 Jan; 57(1):95-102. PubMed ID: 18078865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.
    Glorieux FH; Scriver CR; Reade TM; Goldman H; Roseborough A
    N Engl J Med; 1972 Sep; 287(10):481-7. PubMed ID: 4340235
    [No Abstract]   [Full Text] [Related]  

  • 19. Solomon's epidermal nevus syndrome (type: linear nevus sebaceus) and hypophosphatemic vitamin D-resistant rickets.
    Oranje AP; Przyrembel H; Meradji M; Loonen MC; de Klerk JB
    Arch Dermatol; 1994 Sep; 130(9):1167-71. PubMed ID: 8085871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of fibroblast growth factor 23 for hypophosphatemia and abnormal regulation of vitamin D metabolism in patients with McCune-Albright syndrome.
    Yamamoto T; Imanishi Y; Kinoshita E; Nakagomi Y; Shimizu N; Miyauchi A; Satomura K; Koshiyama H; Inaba M; Nishizawa Y; Jüppner H; Ozono K
    J Bone Miner Metab; 2005; 23(3):231-7. PubMed ID: 15838626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.